Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Cramer

Showing results (131-140 of 145) with videos related to

Pageof 15
Sort By:
The Journal of Cell Biology|May 1, 1986
Effect of human serum and some of its components on neutrophil adherence and migration across an epitheliumE B Cramer, L C Milks, M J Brontoli, et al.
The Annals of Pharmacotherapy|February 26, 1998
Effect of infusion rate on the pharmacokinetics and tolerance of intravenous dolasetron mesylateD C Dimmitt, T L Hunt, A J Spalitto, et al.
Urologic Radiology|January 1, 1988
Sonographic and urographic correlation in Bardet-Biedl syndrome (formerly Laurence-Moon-Biedl syndrome)B Cramer, J Green, J Harnett, et al.
Dental Materials : Official Publication of the Academy of Dental Materials|June 18, 2010
Properties of methacrylate-thiol-ene formulations as dental restorative materialsNeil B Cramer, Charles L Couch, Kathleen M Schreck, et al.
Dental Materials : Official Publication of the Academy of Dental Materials|September 29, 2009
Investigation of thiol-ene and thiol-ene-methacrylate based resins as dental restorative materialsNeil B Cramer, Charles L Couch, Kathleen M Schreck, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 17, 1998
Rationale for the use of a single fixed intravenous dolasetron dose for the prevention of cisplatin-induced nausea and vomiting. Pooled analysis of 14 clinical trialsJ B Whitmore, M G Kris, P J Hesketh, et al.
Dental Materials : Official Publication of the Academy of Dental Materials|December 3, 2010
Thiol-ene-methacrylate composites as dental restorative materialsJordan E Boulden, Neil B Cramer, Kathleen M Schreck, et al.
American Journal of Clinical Oncology|December 1, 1996
Antiemetic efficacy of two different single intravenous doses of dolasetron in patients receiving high-dose cisplatin-containing chemotherapyA Yeilding, L Bertoli, P Eisenberg, et al.
Journal of Strength and Conditioning Research|August 19, 2017
Noninvasive Assessment of Skeletal Muscle Myosin Heavy Chain Expression in Trained and Untrained MenAndrew C Fry, Terry J Housh, Joel B Cramer, et al.
International Forum of Allergy & Rhinology|November 17, 2022
Dupilumab-related adverse events among patients with chronic rhinosinusitis with nasal polyposisDaniel J Lee, Hannah B Cramer, Rijul S Kshirsagar, et al.
Pageof 15

Showing results (131-140 of 145) with videos related to

Sort By:
Pageof 15
The Journal of Cell Biology|May 1, 1986
Effect of human serum and some of its components on neutrophil adherence and migration across an epitheliumE B Cramer, L C Milks, M J Brontoli, et al.
The Annals of Pharmacotherapy|February 26, 1998
Effect of infusion rate on the pharmacokinetics and tolerance of intravenous dolasetron mesylateD C Dimmitt, T L Hunt, A J Spalitto, et al.
Urologic Radiology|January 1, 1988
Sonographic and urographic correlation in Bardet-Biedl syndrome (formerly Laurence-Moon-Biedl syndrome)B Cramer, J Green, J Harnett, et al.
Dental Materials : Official Publication of the Academy of Dental Materials|June 18, 2010
Properties of methacrylate-thiol-ene formulations as dental restorative materialsNeil B Cramer, Charles L Couch, Kathleen M Schreck, et al.
Dental Materials : Official Publication of the Academy of Dental Materials|September 29, 2009
Investigation of thiol-ene and thiol-ene-methacrylate based resins as dental restorative materialsNeil B Cramer, Charles L Couch, Kathleen M Schreck, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 17, 1998
Rationale for the use of a single fixed intravenous dolasetron dose for the prevention of cisplatin-induced nausea and vomiting. Pooled analysis of 14 clinical trialsJ B Whitmore, M G Kris, P J Hesketh, et al.
Dental Materials : Official Publication of the Academy of Dental Materials|December 3, 2010
Thiol-ene-methacrylate composites as dental restorative materialsJordan E Boulden, Neil B Cramer, Kathleen M Schreck, et al.
American Journal of Clinical Oncology|December 1, 1996
Antiemetic efficacy of two different single intravenous doses of dolasetron in patients receiving high-dose cisplatin-containing chemotherapyA Yeilding, L Bertoli, P Eisenberg, et al.
Journal of Strength and Conditioning Research|August 19, 2017
Noninvasive Assessment of Skeletal Muscle Myosin Heavy Chain Expression in Trained and Untrained MenAndrew C Fry, Terry J Housh, Joel B Cramer, et al.
International Forum of Allergy & Rhinology|November 17, 2022
Dupilumab-related adverse events among patients with chronic rhinosinusitis with nasal polyposisDaniel J Lee, Hannah B Cramer, Rijul S Kshirsagar, et al.
Pageof 15